OPANA (OXYMORPHONE HYDROCHLORIDE) — FDA Approval NDA021611 (ENDO PHARMS)
OPANA (OXYMORPHONE HYDROCHLORIDE) — FDA Approval NDA021611 (ENDO PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OPANA; Active ingredients: OXYMORPHONE HYDROCHLORIDE; Application number: NDA021611.
| Brand name | OPANA |
|---|---|
| Active ingredients | OXYMORPHONE HYDROCHLORIDE |
| Application number | NDA021611 |
| Sponsor | ENDO PHARMS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20060622 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →